Figure 6.
ADSCs-hEVs promote the proliferation and migration of cells via the PI3K/AKT. (A) Edu assay showed that ADSCs-hEVs-treated HF proliferation was suppressed by inhibitors LY294002, compared with ADSCs-EVs. *, vs ADSCs-hEVs+Ly; #, vs ADSCs-EVs+Ly; +, vs ADSCs-cEVs+Ly; (B) QRT-PCR analysis of wound tissue mRNA level 14 days after operation, including bFGF, COLI, PDGF, VEGF, TGF-β. (C) After ADSCs-hEVs-treated 0, 3, 7 and 14 days were taken. Data are represented as mean ± SD. *, vs DW+EVs; #, vs DW+PBS; ns, vs DW+PBS; n = 3. *P < 0.05, **P < 0.01, ***P < 0.0001, #P < 0.05, ##P < 0.01, ####P < 0.00001, +++P < 0.0001. Bars, 100μm.